Detalhe da pesquisa
1.
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine.
Rheumatology (Oxford)
; 62(3): 1124-1135, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766806
2.
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Rheumatology (Oxford)
; 62(9): 3133-3138, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637209
3.
The BILAG-2004 index is associated with development of new damage in SLE.
Rheumatology (Oxford)
; 62(2): 668-675, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686924
4.
Primary Sjögren syndrome-related peripheral neuropathy: A systematic review and meta-analysis.
Eur J Neurol
; 30(1): 255-265, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36086910
5.
Flares in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(7): 3262-3267, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325488
6.
Exploring the microcirculatory effects of an exercise programme including aerobic and resistance training in people with limited cutaneous systemic sclerosis.
Microvasc Res
; 125: 103887, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31220505
7.
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
Ann Rheum Dis
; 77(4): 563-570, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29306872
8.
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Rheumatology (Oxford)
; 57(3): 470-479, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216396
9.
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.
Rheumatology (Oxford)
; 57(2): 370-381, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207002
10.
C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis.
Proc Natl Acad Sci U S A
; 112(37): 11618-23, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316022
11.
Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis.
Hum Mol Genet
; 24(19): 5367-77, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26152200
12.
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Ann Rheum Dis
; 76(7): 1207-1218, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188239
13.
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
Rheumatology (Oxford)
; 55(3): 544-52, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510429
14.
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
Rheumatology (Oxford)
; 54(4): 655-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25240612
15.
Health-related utility values of patients with primary Sjögren's syndrome and its predictors.
Ann Rheum Dis
; 73(7): 1362-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23761688
16.
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Rheumatology (Oxford)
; 53(2): 275-84, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24097288
17.
The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients.
Rheumatology (Oxford)
; 51(10): 1877-80, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22763989
18.
The BILAG-2004 systems tally--a novel way of representing the BILAG-2004 index scores longitudinally.
Rheumatology (Oxford)
; 51(11): 2099-105, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908329
19.
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
Rheumatology (Oxford)
; 56(6): 1049, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28549192
20.
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
Rheumatology (Oxford)
; 56(6): 1041-1043, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28431104